Beneficial effects of statins [2]

Lancet

Volumn 348, Issue 9041, 1996, Pages 1582-1583

  Marchioli, R ^a   Tognoni, G ^a   Mikhailidis, D P ^a   Ganotakis, E S ^a   Jagroop, I A ^a   Winder, A F ^a   Rosenson, R S ^a   Tangney, C C ^a   Gurwitz, D ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRINOGEN; MEVINOLIN; SIMVASTATIN; STATIN; DRUG DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SEROTONIN;

HUMAN; LETTER; PRIORITY JOURNAL; BLOOD; NOTE; PHYSIOLOGY;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; FIBRINOGEN; HUMANS; LOVASTATIN; PRAVASTATIN; SEROTONIN; SIMVASTATIN;

EID: 0029828686     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. CJ Vaughan MB Murphy BM Buckley Statins do more than just lower cholesterol Lancet 348 1996 1079 1082
2. DP Mikhailidis IA Jagroop MA Barradas AF Winder Correlations between platelet aggregation, fibrinolysis, peripheral and central serotoninergic measures in subhuman primates Atherosclerosis 113 1995 135
3. NJW Cheshire JHN Wolfe MA Barradas AW Chambler DP Mikhailidis Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infra-inguinal graft stenosis Eur J Vasc Endovasc Surg 11 1996 479 486
4. A Branchi A Rovellini D Sommariva AG Gugliandolo A Fasoli Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolaemia Thromb Haemostas 70 1993 241 243
5. C-G Ericsson A Hamsten J Nilsson L Grip B Svane de Faire U Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients Lancet 347 1996 849 853